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Genetic-and-Epigenetic Interspecies
Networks for Cross-Talk
Mechanisms in Human Macrophages
and Dendritic Cells during MTB
Infection
Cheng-Wei Li, Yun-Lin Lee and Bor-Sen Chen*
Laboratory of Control and Systems Biology, National Tsing Hua University, Hsinchu, Taiwan
Tuberculosis is caused by Mycobacterium tuberculosis (Mtb) infection. Mtb is one of
the oldest human pathogens, and evolves mechanisms implied in human evolution. The
lungs are the first organ exposed to aerosol-transmitted Mtb during gaseous exchange.
Therefore, the guards of the immune system in the lungs, such as macrophages (Mφs)
and dendritic cells (DCs), are the most important defense against Mtb infection. There
have been several studies discussing the functions of Mφs and DCs duringMtb infection,
but the genome-wide pathways and networks are still incomplete. Furthermore, the
immune response induced byMφs and DCs varies. Therefore, we analyzed the cross-talk
genome-wide genetic-and-epigenetic interspecies networks (GWGEINs) between Mφs
vs. Mtb and DCs vs. Mtb to determine the varying mechanisms of both the host and
pathogen as it relates to Mφs and DCs during early Mtb infection. First, we performed
database mining to construct candidate cross-talk GWGEIN between human cells and
Mtb. Then we constructed dynamic models to characterize the molecular mechanisms,
including intraspecies gene/microRNA (miRNA) regulation networks (GRNs), intraspecies
protein-protein interaction networks (PPINs), and the interspecies PPIN of the cross-talk
GWGEIN. We applied a system identification method and a system order detection
scheme to dynamic models to identify the real cross-talk GWGEINs using the microarray
data of Mφs, DCs and Mtb. After identifying the real cross-talk GWGEINs, the principal
network projection (PNP) method was employed to construct host-pathogen core
networks (HPCNs) between Mφs vs. Mtb and DCs vs. Mtb during infection process.
Thus, we investigated the underlying cross-talk mechanisms between the host and the
pathogen to determine how the pathogen counteracts host defense mechanisms in Mφs
and DCs duringMtb H37Rv early infection. Based on our findings, we propose Rv1675c
as a potential drug target because of its important defensive role in Mφs. Furthermore,
the membrane essential proteins v1098c, and Rv1696 (or cytoplasm for Rv0667), inMtb
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could also be potential drug targets because of their important roles in Mtb survival in
both cell types. We also propose the drugs Lopinavir, TMC207, ATSM, and GTSM as
potential therapeutic treatments for Mtb infection since they target the above potential
drug targets.
Keywords: genetic and epigenetic interspecies network, macrophages, dendritic cells, Mycobacterium
tuberculosis infection, cross-talk mechanism, multi-molecule drug, potential drug targets, principal network
projection (PNP)
INTRODUCTION
Tuberculosis (TB) is an ancient disease of humankind,
accounting for a significant number of deaths over the years.
According to the World Health Organization (WHO) Global
Health Observatory (GHO) data for 2014, approximately 9.6
million new cases of TB are identified each year, with almost 1.5
million TB related deaths. Approximately one-third of the global
population harbor this bacterium but remain asymptomatic, also
known as latent TB (Dye et al., 1999). Of those with latent TB,
only 5–10% will develop into active TB disease in their lifetime
(Vynnycky and Fine, 2000). The main etiologic agent of TB is
Mycobacterium tuberculosis (Mtb), which was first identified as a
pathogen by Robert Koch in 1882 (Koch, 1982).
Dendritic cells (DCs), which are involved in the first line of
immune defense, protect tissues from extraneous bacilli or viral
infection. DCs also phagocytose Mtb, process the bacilli, and
present the mycobacterial antigens on the plasma membrane.
The DCs migrate to the regional lymph nodes where they
prime T cells by presenting antigens on MHC and secrete
cytokines. DCs in peripheral tissue capture and process antigens
in different ways: (1) macropinocytosis (Sallusto et al., 1995),
(2) endocytosis via receptors such as the mannose receptor
DEC-205 or dendritic cell specific ICAM 3 grabbing non-
integrin (DC-SIGN) (Geijtenbeek et al., 2000), (3) Fc receptors
and complement receptors (CR3), which mediate efficient
internalization of immune complexes or bacteria (Rescigno et al.,
2000), (4) phagocytosis of viruses or bacteria (Albert et al., 1998),
(5) TLR-mediated pathogen recognition (Visintin et al., 2001).
The interactions between DCs and Mtb are still not fully
understood and some reports are contradictory. For instance,
Abbreviations: AIC, Akaike information criterion; ANOVA, analysis of variance;
APC, antigen presenting cell; APP, amyloid precursor protein; BCG, bacille
Calmette-Guérin; CR, complement receptor; Cu, copper; DALIS, dendritic cell
aggresome-like induced structures; DCs, dendritic cells; DC-SIGN, dendritic cell
specific ICAM 3 grabbing non-integrin; DosR, dormancy survival regulator;
GO, gene ontology; GRN, gene/miRNA regulation network; GWGEIN, cross-
talk genome-wide genetic-and-epigenetic interspecies network; HPCN, host-
pathogen core network; LAM, Lipoarabinomannan; MDR-TB, multi-drug
resistance tuberculosis; MHC-II, major histocompatibility complex class II;
miRNA, microRNA; Mtb, mycobacterium tuberculosis; Mφ macrophage; NCBI,
National Center for Biotechnology Information; NO, nitric oxide; PKA, cAMP-
dependent protein kinase; PNP, principal network projection; PPD, purified
protein derivative; PPI, protein-protein interaction; PPINs, protein-protein
interaction networks; RIα, type 1α regulatory subunit; RNIs, reactive nitrogen
intermediates; ROS, reactive oxygen species; RPS10, Ribosomal protein S10;
SLAM, signaling lymphocyte activation molecule; TF, transcription factor; Th1,
T helper type 1; TLR, toll-like receptor; and XDR-TB, extensive drug resistance
tuberculosis.
after interacting with pathogens, DCs mature and migrate to
lymph nodes where they prime T cells by presenting antigens
on MHC and secrete cytokines such as IL-12 (Lipscomb and
Masten, 2002). In contrast, a study reported that interaction
of Mtb with TLRs induce high IL-12 secretion during early
infection whereas interactionwithDC-SIGN results in high IL-10
secretion (Kaufmann and Schaible, 2003).
After Mtb is phagocytosed by alveolar macrophages (Mφs),
ligation of TLR2 and TLR4 stimulates the secretion of
proinflammatory cytokines such as TNF-α, IL-1β, and IL-12
(Means et al., 1999). TNF-α plays an important role in the
immune response to Mtb infection by stimulating neutrophils
and Mφs in an autocrine and paracrine fashion to induce
apoptosis and production of reactive nitrogen intermediates
(RNIs). Nitric oxide, an iNOS product, is highly toxic to
intracellular mycobacteria (Chan et al., 1992). NOS2-deficient
mice showed increased susceptibility to mycobacterial infection
(Garcia et al., 2000). Some studies reported that TNF-α is
important in preventing the reactivation of latent TB in non-
human primate and mouse models (Scanga et al., 1999; Lin
et al., 2010). IL-1β was correlated to disease activity and fever in
infected patients (Tsao et al., 1999). IL-12 is important in driving
T helper type 1 (Th1) differentiation and IFN-γ production. The
increased susceptibility of IL-12p40 gene deficient mice to Mtb
infection further supports an important role for IL-12 in the
protective immune response against Mtb (Cooper et al., 1997).
However, IFN-γ is the most important cytokine in the immune
response to mycobacteria, and it plays a role in activating Mφs
to produce reactive oxygen and nitrogen species. IFN-γ deficient
mice are highly susceptible to Mtb infection and produce less
NOS2 (Flynn et al., 1993).
The host immune response is often insufficient for handling
Mtb infection as the bacterium has developed sophisticated
defense mechanisms such as blocking maturation, lysosomal
fusion, and acidification to survive in Mφs and enhance the
growth of bacteria. The 19-kDa lipoprotein of Mtb interacts
with host antigen presenting cells (APCs) via TLR1/2 to reduce
antigen processing and MHC-II expression (Noss et al., 2001),
rather than inhibiting cytokine production (Sugawara et al.,
2003). ESAT-6 has a similar effect through TLR-2 (Pathak
et al., 2007). Lipoarabinomannan (LAM) is a major cell wall
component ofMtb that binds to DC-SIGN. The binding of LAM
inhibits DCmaturation, decreases IL-12 production, and induces
DCs to secrete IL-10 (van Kooyk and Geijtenbeek, 2003). IL-10
is an immune suppressive cytokine, and its induction by Mtb
allows survival of the bacteria (Redford et al., 2011). Blocking the
accumulation of ATPases and GTPases in the vacuole interferes
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with the function of the phagosome by decreasing the pH
needed to kill the bacteria (Sturgill-Koszycki et al., 1994). Other
mechanisms of Mtb immune evasion have been thoroughly
outlined in a previous review (Sakamoto, 2012).
Although, a few studies investigated the effects of human
microRNAs (miRNAs) on Mtb-infected Mφ (Rajaram et al.,
2011; Kumar et al., 2012) and DC (Chatterjee et al., 2011;
Singh et al., 2013), it is still a big issue to identify the cross-
talk genome-wide genetic-and-epigenetic interspecies networks
(GWGEINs) between pathogen and host both in Mφs and DCs
during Mtb infection. Additionally, the different offensive and
defensive mechanisms between Mφs vs. Mtb and DCs vs. Mtb
play important roles in the evaluation of potential drugs for
treating human cells during early Mtb infection. In this study,
we identified the cross-talk GWGEINs in both human Mφs
and DCs during early Mtb infection through systems biology
approach. We proposed the common and different pathways of
the host-and-pathogen core networks (HPCNs), extracted from
the cross-talk GWGEINs, to investigate the cellular mechanisms
of both host and pathogen in Mφs and DCs during early Mtb
infection. Moreover, we also discussed the cross-talks between
host and pathogen and inferred the core network biomarkers to
get an insight into offensive and defensive mechanisms both in
Mφs vs.Mtb and DCs vs.Mtb. Finally, based on the core network
biomarkers of offensive and defensive mechanisms betweenMφs,
DCs and Mtb, we proposed the potential multiple drug targets
and suggested the potential multi-molecule drug for treating
human cells during earlyMtb infection.
MATERIALS AND METHODS
Overview of the Construction Processes of
Cross-Talk GWGEINs in Mφs and DCs
Infected with Mtb
The flowchart of the strategy for constructing cross-talk
GWGEINs and the HPCNs in Mφs and DCs during early
Mtb infection is shown in Figure 1. The cross-talk GWGEIN
comprises host/pathogen gene/miRNA regulation networks
(GRNs), host/pathogen protein-protein interaction networks
(PPINs), the interspecies PPIN and the regulation networks of
host-miRNAs on host-/pathogen-genes. The constructions of
GWGEIN and HPCN can be divided into three steps: (1) Big
data mining and data preprocessing for candidate cross-talk
GWGEINs, (2) the identification of the real cross-talk GWGEIN
by applying the system identification method and the system
order detection scheme using the genome-wide microarray data
of Mφs, DCs, and Mtb during early Mtb infection, (3) HPCN
construction by applying principal network projection (PNP) to
the real cross-talk GWGEIN. This allowed identification of the
differential cross-talk mechanisms betweenMφs and DCs during
earlyMtb infection.
Big Data Mining and Data Preprocessing
In this study, in order to identify the real cross-talk GWGEIN
between human cells and Mtb, the simultaneously measured
activities of host and pathogen during infection process were
required. Since several gene expression profiles are available only
on the host side (Realegeno et al., 2016) or only on the pathogen
side (Fontán et al., 2008) duringMtb infection, those data was not
suitable for identifying the offensive and defensive mechanisms
between host and pathogen during infection process. Therefore,
in this study, the microarray raw data, obtained from a previous
study investigating Mφs and DCs infected with Mtb (Tailleux
et al., 2008), were the only one that presents all the data necessary
to build the model of the cross-talk GWGEIN. This issue was also
a limitation of the model as well. These assumptions should be
revised as more data becomes available.
The raw data has two parts. The first part includes the mRNA
and miRNA expression levels of human Mφs and DCs at 0,
4, 18, and 48 h post-infection with Mtb H37Rv (ArrayExpress
accession number E-MEXP-3521). The second part includes
the Mtb transcriptional mRNA expression levels in Mφs and
DCs at 0, 1, 4, and 18 h post infection (ArrayExpress accession
number E-BUGS-58; http://www.ebi.ac.uk/arrayexpress/
experiments/browse.html). The probing platforms used in
the host and pathogen were Affymetrix GeneChip Human
Genome HG-U133A and M. tuberculosis/M. bovis 10944
YBv2_1_1, respectively, which contained 22283 and 10944
probes, respectively. The data of human Mφs at 0, 4, 18 h and
Mtb at 0, 1, 4, 18 h during infection process were employed to
identify the real cross-talk GWGEIN between Mφs and Mtb,
while the data of human DCs at 0, 4, 18 h and Mtb at 0, 1, 4, 18
h during infection process were employed to identify the real
cross-talk GWGEIN between DCs and Mtb. In fact, we used
cubic spline to obtain the sufficient number of data points for
applying system identification method. Therefore, in human
Mφs and DCs, we applying cubic spline to the data at 0, 4, 18,
and 48 h to obtain the sufficient number of data points between 0
and 18 h to avoid overfitting problem in parameter identification
process.
Constructing the candidate cross-talk GWGEIN requires big
data obtained from experimental or computational predictions.
The big data, which collected from several databases, were as
follows. The host candidate GRN required miRNA for regulatory
gene associations from TargetScanHuman (Agarwal et al., 2015),
transcription factors (TFs) to regulatory gene associations from
GSEA (Mootha et al., 2003; Subramanian et al., 2005), HTRIdb
(Bovolenta et al., 2012), and ITFP (Zheng et al., 2008). The
host candidate PPIN need protein-protein interaction (PPI)
associations from BioGRID (Stark et al., 2006). The pathogen
candidate GRN required TF for gene regulatory associations from
TbDb (Galagan J. et al., 2013; Galagan J. E. et al., 2013; Jaini
et al., 2014), the data in Minch et al. (2015) and the host-miRNAs
targeting pathogen-gene associations in Guo et al. (2010).
The pathogen candidate PPIN required PPI associations from
STRING (Szklarczyk et al., 2015), and the study in Wang et al.
(2010). The host-pathogen candidate PPIN required interspecies
PPI associations from the study in Davis et al. (2007) and Zhou
et al. (2014).
In order to support inferred epigenetic DNA methylation, we
used the genome-wide DNA methylation profiles of monocytes
(GSE70478) (Esterhuyse et al., 2015) and DCs (GSE64177)
(Pacis et al., 2015) infected with Mtb (with sample size
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FIGURE 1 | Flow chart of networks constructed using the systems biology approach. The construction of candidate GWGEINs requires several association
databases as Cylinder blocks. We used network models and genome-wide high throughput data to identify the regulative and interactive abilities in candidate
GWGEINs, and pruned the false-positives of candidate GWGEINs by deleting the insignificant components out of system order as determined by Akaike information
criterion (AIC). Then GWGEINs in Mφs and DCs were constructed to represent the real cellular network of biological systems. Finally, we extracted host-pathogen core
networks (HPCNs) from GWGEINs by principal network projection (PNP) to investigate the defensive mechanisms of the host and pathogen in Mφs and DCs during
Mtb infection. The multiple drug targets are also selected based on core network markers of HPCNs for potential multi-molecule drug design through drug design
literature search.
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10 and 6, respectively). According to the DNA methylation
analysis of monocytes and macrophages, only 27 CpG sites
displayed differential DNA methylation during the maturation
step (Vento-Tormo et al., 2016). Therefore, the DNAmethylation
analysis between monocytes and DCs could represent that
between Mφs and DCs. Methylation data were analyzed using
one-way analysis of variance (ANOVA) statistics.
To integrate the above big data, including genome-wide
expression data, the data for constructing the candidate cross-talk
GWGEIN, and genome-wide DNAmethylation profiles, we used
Matlab’s text-file and string manipulation tools in text mining to
unify the gene name based on the gene symbols in the National
Center for Biotechnology Information’s (NCBI’s) Gene database.
Therefore, in host candidate GRN, we obtained 445,335 TF
gene pairs and 411,418 miRNA gene pairs. In the databases of
pathogen candidate GRN, we obtained 85,916 TF gene pairs and
12 miRNA gene pairs. In the databases of interspecies candidate
PPIN, we obtained 1,101,388 host PPI pairs, 1868 pathogen PPI
pairs, and 10,536 host-pathogen interspecies PPI pairs. Finally,
we integrated the candidate pairs into the candidate cross-talk
GWGEIN (Figure 1). The candidate cross-talk GWGEIN was
then used to identify the real cross-talk GWGEINs in Mφs and
DCs by applying the system identificationmethod and the system
order detection scheme using the genome-wide microarray data
of Mφs, DCs andMtb during earlyMtb infection.
Dynamic Models of the Cross-Talk
GWGEIN for Mφs, DCs, and Mtb during
Early Infection Process
Because all connections in the candidate GWGEINwere obtained
from a number of plausible predictions in human cells and Mtb,
we then constructed the dynamic models of GWGEIN, which
characterize the molecular mechanisms in GWGEIN, to prune
false-positive connections using genome-wide microarray data
and finally obtained the real cross-talk GWGEIN between Mφs
andMtb (or DCs andMtb) during infection process.
For the GRN of host genes in GWGEIN, the dynamic model
of the ith host-gene can be described as the following stochastic
dynamic equation,
xi (t + 1) = xi(t)+
Ji∑
j= 1
aijyj(t)−
Ki∑
k= 1
cikxi(t)miRNAk(t)
− λixi(t)+ δi + ωi(t), for i = 1, · · · , I
(1)
where xi(t), yj(t), and miRNAk(t) represent the expression levels
of the ith host-gene, the jth host-TF, and the kth host-miRNA
at time t, respectively; aij and −cik denote the abilities of the
jth host-TF regulation and the kth host-miRNA repression on
the ith host-gene; δi and −λi indicate the basal level and the
degradation rate of the ith host-gene, respectively; Ji and Ki
signify the numbers of host TFs and miRNAs regulating the ith
host-gene in the candidate GWGEIN; and ωi(t) is the stochastic
noise of the ith host-gene due to modeling residue. The dynamic
model of host genes in (1) characterized molecular mechanisms,
including the transcription regulations by
∑Ji
j= 1 aijyj(t), the
miRNA repressions by −
∑Ki
k= 1
cikxi(t)miRNAk(t), the mRNA
degradation by −λixi(t), the basal level by δi, and the stochastic
noise by ωi(t). Owing to the direct effects of DNAmethylation on
the binding affinities of RNA polymerase to target genes (Weber
et al., 2007), we assumed that the change of basal level δi between
theMtb-infected Mφs and theMtb-infected DCs in the dynamic
model (1) indicates the occurrence of methylation on the ith
host-gene.
For the PPIN of host proteins in GWGEIN, the dynamic
model of the jth host-protein can be described as the following
stochastic dynamic equation,
yj(t + 1) = yj(t)+
Jj∑
l= 1
bjlyj(t)yl(t)+
Mj∑
m= 1
djmyj(t)wm(t)
+ αjxj(t)− γjyj(t)+ κj +̟j(t), for j = 1, · · · , J
(2)
where yj(t), yl(t), xj(t), and wm(t) represent the expression levels
of the jth host-protein, the lth host-protein, the jth host-gene
and the mth pathogen-protein at time t, respectively; bjl and
djm denote the interactive abilities between the jth host-protein
and lth host-protein and between the jth host-protein and the
mth pathogen-protein, respectively; αj, −γj, and κj indicate
the translation rate, the degradation rate and the basal level
of the jth host-protein; Jj and Mj signify the numbers of host
proteins and pathogen proteins interacting with the jth host-
protein in the candidate GWGEIN; and ω¯j(t) is the stochastic
noise due to modeling residue. The dynamic model of host
proteins in (2) characterized molecular mechanisms, including
the intraspecies host PPIs by
∑Jj
l= 1
bjlyj(t)yl(t), the interspecies
PPIs by
∑Mj
m= 1 djmyj(t)wm(t), the protein translation by αjxj(t),
the protein degradation by−γjyj(t), the basal level by κj, and the
stochastic noise by ωj(t).
For the GRN of pathogen genes in GWGEIN, the dynamic
model of the nth pathogen-gene can be described as the following
stochastic dynamic equation,
vn(t + 1) = vn(t)+
Mn∑
m= 1
enmwm(t)−
Kn∑
k= 1
gnkvn(t)miRNAk(t)
− ρnvn(t)+ ηn + ψn(t),
for n = 1, · · · ,N (3)
where vn(t) represents the expression level of the nth pathogen-
gene at time t; enm and −gnk denote the abilities of the mth
pathogen-TF regulation and the kth host-miRNA repression
on the nth pathogen-gene, respectively; ηn and −ρn indicate
the basal level and the degradation rate of the nth pathogen-
gene, respectively; Mn and Kn signify the numbers of pathogen
TFs and host miRNAs regulating the nth pathogen-gene in the
candidate GWGEIN; and ψn(t) is the stochastic noise due to
modeling residue. The dynamic model of pathogen genes in
(3) characterized molecular mechanisms, including the pathogen
transcription regulations by
∑Mn
m= 1 enmwm(t), the host miRNA
repressions by −
∑Kn
k= 1
gnkvn(t)miRNAk(t),the pathogen mRNA
degradation by −ρnvn(t), the pathogen basal level by ηn, and
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the stochastic noise by ψn(t). Because it has been proposed
that miRNAs can exist extracellularly and circulate in body
fluid (Weber et al., 2010; Liu et al., 2016), we considered the
repressions of host-miRNAs on pathogen-genes in the dynamic
model (3) of GWGEIN.
For the PPIN of pathogen proteins in GWGEIN, the dynamic
model of the mth pathogen-protein can be described as the
following stochastic dynamic equation,
wm(t + 1) = wm(t)+
Mm∑
q= 1
hmqwm(t)wq(t)+
Jm∑
j= 1
dmjwm(t)yj(t)
+ βmvm(t)− σmwm(t)+ εm + τm(t),
form = 1, · · · ,M (4)
where wq(t) and wm(t) represent the expression level of the
qth pathogen-protein and the mth pathogen-protein at time t;
hmq and dmj denote the interactive abilities between the mth
pathogen-protein and qth pathogen-protein and between the
mth pathogen-protein and the jth host-protein, respectively; βm,
−σm, and εm indicate the translation rate from the mRNA
of the mth pathogen-gene vm, and the degradation rate and
the basal level of the mth pathogen-protein; Mm and Jm
signify the numbers of pathogen proteins and host proteins
interacting with the mth pathogen-protein in the candidate
GWGEIN; and τm(t) is the stochastic noise due to modeling
residue. The dynamic model of pathogen proteins in (4)
characterized molecular mechanisms, including the intraspecies
pathogen PPIs by
∑Mm
q= 1 hmqwm(t)wq(t), the interspecies PPIs
by
∑Jm
j= 1 dmjwm(t)yj(t), the protein translation by βmvm(t), the
protein degradation by -σmwm(t), the basal level by εm, and the
stochastic noise by τm(t).
System Identification Method of the
Dynamic Models of GWGEIN
After constructing the stochastic dynamic Equations (1–4) in
the GWGEIN, we applied a system identification method to the
Equations (1)–(4) to identify their respective parameters. The
host GRN Equation (1) was rewritten as the following linear
regression form,
xi(t + 1) =
[
y1(t) · · · yJi (t) xi(t)miRNA1(t)
· · · xi(t)miRNAKi (t) xi(t) 1
]


ai1
...
aiJi
−ci1
...
−ciKi
1− λi
δi


+ ωi(t) (5)
which could be simply represented as follows,
xi(t + 1) = φ
HG
i (t)θ
HG
i + ωi(t), for i = 1,
... , I (6)
where ΦHGi (t) denotes the regression vector obtained from the
corresponding expression data; and θHGi represents the unknown
parameter vector of the host gene i in the host GRN to be
estimated.
The Equation (6) can be augmented for Fi time points of the
ith host-gene as follows,


xi(t2)
xi(t3)
...
xi(tFi + 1)

 =


φHGi (t1)
φHGi (t2)
...
φHGi (tFi )

 θ
HG
i +


ωi(t1)
ωi(t2)
...
ωi(tFi )

 (7)
For simplicity, we defined the notations XHGi , 8
HG
i , and Ŵ
HG
i to
represent (7) as follows,
XHGi = 8
HG
i θ
HG
i + Ŵ
HG
i (8)
where XHGi =


xi(t2)
xi(t3)
...
xi(tFi + 1)

 ,8
HG
i =


φHGi (t1)
φHGi (t2)
...
φHGi (tFi )

 , and
ŴHGi =


ωi(t1)
ωi(t2)
...
ωi(tFi )

 .
The system identification method of the host GRN Equation (1)
can then be formulated by the following constrained least square
parameter estimation problem,
min
θHGi
1
2
∥∥8HGi θHGi − XHGi
∥∥2
2
(9)
Subject to
Ji︷ ︸︸ ︷

0 · · · 0
...
. . .
...
0 · · · 0
0 · · · 0
0 · · · 0
Ki︷ ︸︸ ︷
1 · · · 0
...
. . .
...
0 · · · 1
0 · · · 0
0 · · · 0
0 0
...
...
0 0
1 0
0 −1


θHGi ≤


0
...
0
1
0


By solving the problem in (9), we can obtain the parameters in
the host GRN Equation (1) and simultaneously guarantee the
non-positive host-miRNA repression −cik≤ 0, the non-positive
host-gene degradation −λi ≤ 0, and the non-negative host-gene
basal level δi ≥ 0.
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Similarly, the host PPIN Equation (2) can be rewritten in the
following linear regression form,
yj(t + 1) =
[
yj(t)y1(t) · · · yj(t)yJj(t) yj(t)w1(t)
· · · yj(t)wMj (t) xj(t) yj(t) 1
]


bj1
...
bjJj
dj1
...
djMj
αj
1− γj
κj


+̟j(t)
(10)
which could be simply represented as follows,
yj(t + 1) = φ
HP
j (t)θ
HP
j +̟j(t), for j = 1,
... , J (11)
where ΦHPj (t) denotes the regression vector obtained from the
corresponding expression data; and θHPj represents the unknown
parameter vector of the host protein j in the host PPIN to be
estimated. The Equation (11) can be augmented for Fj time points
of the jth host-protein as follows,
YHPj = 8
HP
j θ
HP
j + Ŵ
HP
j (12)
where YHPj =


yj(t2)
yj(t3)
...
yj(tFj + 1)

 ,8
HP
j =


φHPj (t1)
φHPj (t2)
...
φHPj (tFj )

 , and
ŴHPj =


̟j(t1)
̟j(t2)
...
̟j(tFj )

 .
The system identification method of the host PPIN Equation (2)
can then be formulated by the following constrained least square
parameter estimation problem,
min
θHPj
1
2
∥∥∥8HPj θHPj − YHPj
∥∥∥2
2
(13)
Subject to
Jj+Mj︷ ︸︸ ︷
0 · · · 00 · · · 0
0 · · · 0
−1 0 0
0 1 0
0 0 −1

 θHPj ≤

01
0


By solving the problem in (13), we can obtain the parameters
in the host PPIN Equation (2) and simultaneously guarantee
the non-negative host-protein coding rate αj ≥ 0, the non-
positive host-protein degradation−γj ≤ 0, and the non-negative
host-protein basal level κj ≥ 0.
As the same process in host GRN Equation (5), the pathogen
GRN Equation (3) can be rewritten as follows,
vn(t + 1) =
[
w1(t) · · · wMn (t) vn(t)miRNA1(t)
· · · vn(t)miRNAKn (t) vn(t) 1
]


en1
...
enMn
−gn1
...
−gnKn
1− ρn
ηn


+ ψn(t)
(14)
which could be simply represented as follows,
vn(t + 1) = φ
PG
n (t)θ
PG
n + ψn(t), for n = 1,
... ,N (15)
where ΦPGn (t) denotes the regression vector obtained from the
corresponding expression data; and θPGn represents the unknown
parameter vector of the pathogen gene n in the pathogen GRN
to be estimated. The Equation (15) can be augmented for Fn time
points of the nth pathogen-gene as follows,
VPGn = 8
PG
n θ
PG
n + Ŵ
PG
n (16)
where VPGn =


vn(t2)
vn(t3)
...
vn(tFn + 1)

 ,8
PG
n =


φPGn (t1)
φPGn (t2)
...
φPGn (tFn )

 , and
ŴPGn =


ψn(t1)
ψn(t2)
...
ψn(tFn )

 .
The system identificationmethod of the pathogen GRN Equation
(3) can then be formulated by the following constrained least
square parameter estimation problem,
min
θPGn
1
2
∥∥8PGn θPGn − VPGn
∥∥2
2
(17)
Subject to
Mn︷ ︸︸ ︷

0 · · · 0
...
. . .
...
0 · · · 0
0 · · · 0
0 · · · 0
Kn︷ ︸︸ ︷
1 · · · 0
...
. . .
...
0 · · · 1
0 · · · 0
0 · · · 0
0 0
...
...
0 0
1 0
0 −1


θPGn ≤


0
...
0
1
0


By solving the problem in (17), we can obtain the parameters in
the pathogen GRN Equation (3) and simultaneously guarantee
the non-positive host-miRNA repression −gnk ≤ 0, the non-
positive pathogen-gene degradation −ρn ≤ 0, and the non-
negative pathogen-gene basal level ηn ≥ 0.
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As the same process in host PPIN Equation (10), the pathogen
PPIN equation (4) can be rewritten in the following linear
regression form,
wm(t + 1) =
[
wm(t)w1(t) · · · wm(t)wMm (t) wm(t)y1(t)
· · · wm(t)yJm(t) vn(t) wm(t) 1
]


hm1
...
hmMm
dm1
...
dmJm
βm
1− σm
εm


+ τm(t)
(18)
which could be simply represented as follows,
wm(t + 1) = φ
PP
m (t)θ
PP
m + τm(t), form = 1,
... ,M (19)
where ΦPPm (t) denotes the regression vector obtained from the
corresponding expression data; and θPPm represents the unknown
parameter vector of the pathogen protein m in the pathogen
PPIN to be estimated. The Equation (19) can be augmented for
Fm time points of themth pathogen-protein as follows,
WPPm = 8
PP
m θ
PP
m + Ŵ
PP
m (20)
where WPPm =


wm(t2)
wm(t3)
...
wm(tFm + 1)

 ,8
PP
m =


φPPm (t1)
φPPm (t2)
...
φPPm (tFm )

 , and
ŴPPm =


τm(t1)
τm(t2)
...
τm(tFm )


The system identificationmethod of the pathogen PPIN equation
(4) can then be formulated by the following constrained least
square parameter estimation problem,
min
θPPm
1
2
∥∥8PPm θPPm −WPPm
∥∥2
2
(21)
Subject to
Mm+Jm︷ ︸︸ ︷
0 · · · 00 · · · 0
0 · · · 0
−1 0 0
0 1 0
0 0 −1

 θPPm ≤

01
0


By solving the problem in (21), we can obtain the parameters in
the pathogen PPIN Equation (4) and simultaneously guarantee
the non-negative pathogen-protein coding rate βm ≥ 0, the non-
positive pathogen-protein degradation −σm ≤ 0, and the non-
negative pathogen-protein basal level εm ≥ 0. For the accuracy
of the system identification method, we needed to interpolate
extra time points (5 times number of the parameters, θHGi in
host GRN, θHPj in host PPIN, θ
PG
n in pathogen GRN, and θ
PP
m in
pathogen PPIN to be estimated) by using the cubic spline method
to avoid the overfitting in the parameter estimation process
(Johansson, 1993). The solutions of the above constrained least
square parameter estimation problems in (9), (13), (17), and
(21) can be obtained by using the function lsqlin in MATLAB
optimization toolbox based on a reflective Newton method
for minimizing a quadratic function (Coleman and Li, 1996).
The connection weights in cross-talk GWGEIN in Mφs and
Mtb (or DCs and Mtb) during infection process can be finally
solved one gene by one gene (or one protein by one protein)
by using the corresponding microarray data. Since genome-
wide expression measurement of protein behaviors in Mφs, DCs
and Mtb have not been realized yet and gene expressions are
proportional to their corresponding proteins, in which 73%
variance of protein abundance can be explained by mRNA
abundance (Lu et al., 2007), the microarray of gene expressions
can replace protein expressions for the above constrained
least square parameter estimation problems in (9), (13), (17)
and (21).
System Order Detection Scheme of the
Dynamic Models of GWGEIN
Owing to the candidate cross-talk GWGEIN obtained from all
computational and experimental predictions, we the applied a
system order detection scheme to the host GRN model in (6),
the host PPIN model in (11), the pathogen GRN model in (15)
and the pathogen PPIN model in (19) to prune false-positives
in the candidate network using the microarray data of Mφs,
DCs and Mtb. Based on the theory of system identification
(Johansson, 1993), the insignificant parameters in the models of
GWGEIN that were out of system order (association number
in network) were deleted according to Akaike information
criterion (AIC). Therefore, false-positives of the candidate cross-
talk GWGEIN were deleted by AIC using the microarray
data of Mφs, DCs and Mtb and we finally obtained the real
cross-talk GWGEINs between Mφs and Mtb and between DCs
and Mtb during infection process. In host GRN model (6),
AIC of the ith host-gene could be defined by the following
equation,
AICHGi (Ji + Ki) = log

 1Fi
tFi∑
t= 1
(xi(t + 1)− φ
HG
i (t)θˆ
HG
i )
T
(xi(t + 1)− φ
HG
i (t)θˆ
HG
i )


+
2(Ji + Ki)
Fi
(22)
where θˆHGj denotes the estimated parameter of the ith host
gene by solving the problem in (9); and the estimated residual
error is σˆ 2HG,i =
∑tFi
t= 1 (xi(t + 1)− φ
HG
i (t)θˆ
HG
i )
T
(xi(t + 1) −
φHGi (t)θˆ
HG
i ) /Fi. By the tradeoff between residual error and
parameter association number, the minimum AICHGi in (22) can
be achieved at the number J∗i + K
∗
i of the real gene/miRNA
regulations in host GRN (Johansson, 1993; Li and Chen, 2016;
Li et al., 2016). Therefore, the real host GRN of the cross-talk
GWGEIN can be solved by theminimumAICHGi in (22) one gene
by one gene.
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Similarly, in host PPINmodel (11), AIC of the jth host-protein
could be defined by the following equation,
AICHPj (Jj +Mj) = log


1
Fj
tFj∑
t= 1
(yj(t + 1)− φ
HP
j (t)θˆ
HP
j )
T
(yj(t + 1)− φ
HP
j (t)θˆ
HP
j )


+
2(Jj +Mj)
Fj
(23)
where θˆHPj denotes the estimated parameter of the jth host
protein by solving the problem in (13); and the estimated
residual error is σˆ 2HP,j =
∑tFj
t= 1 (yj(t + 1)− φ
HP
j (t)θˆ
HP
j )
T
(yj(t +
1) − φHPj (t)θˆ
HP
j )/Fj. By the tradeoff between residual error and
parameter association number, the minimum AICHPj in (23) can
be achieved at the number J∗j + M
∗
j of the real PPIs in host
PPIN. Therefore, the real host PPIN of the cross-talk GWGEIN
can be solved by the minimum AICHPj in (23) one protein by
one protein. Similar to the above definitions in host GRN (22)
and PPIN (23), AICs of the nth pathogen-gene and the mth
pathogen-protein could be respectively defined by the following
equations,
AICPGn (Mn + Kn) = log

 1Fn
tFn∑
t= 1
(vn(t + 1)− φ
PG
n (t)θˆ
PG
n )
T
(vn(t + 1)− φ
PG
n (t)θˆ
PG
n )


+
2(Mn + Kn)
Fn
(24)
AICPPm (Mm + Jm) = log

 1Fm
tFm∑
t= 1
(wm(t + 1)− φ
PP
m (t)θˆ
PP
m )
T
(wm(t + 1)− φ
PP
m (t)θˆ
PP
m )


+
2(Mm + Jm)
Fm
(25)
where θˆPGn and θˆ
PP
m denote the estimated parameters of the
nth pathogen-gene and the mth pathogen-protein by solving
the problem in (17) and (21), respectively; and the estimated
residual errors of the nth pathogen-gene and the mth pathogen-
protein are σˆPG,n
2 =
∑tFn
t= 1(vn(t + 1)− φ
PG
n (t)θˆ
PG
n )
T (vn(t + 1)
− φPGn (t)θˆ
PG
n ) /Fn and σˆPP,m
2 =
∑tFm
t= 1(wm(t + 1)− φ
PP
m (t)θˆ
PP
m )
T
(wm(t + 1) − φ
PP
m (t)θˆ
PP
m ) /Fm, respectively. By the tradeoff
between residual error and parameter association number, the
minimum AICPGn in (24) and the minimum AIC
PP
m in (25) can
be achieved at the numbers M∗n + K
∗
n of the real gene/miRNA
regulations in pathogen GRN and at the numbers M∗m + J
∗
m of
the real PPIs in pathogen PPIN, respectively. Therefore, the real
pathogen GRN and PPIN of the cross-talk GWGEIN can be
solved by the minimum AICPGn in (24) and the minimum AIC
PP
m
in (25), respectively.
By applying a system identification method and a system
order detection scheme to the dynamic models of the cross-
talk GWGEIN combined with the candidate cross-talk GWGEIN
using the microarray data of Mφs, DCs and Mtb, we can then
identified the real cross-talk GWGEINs between Mφs and Mtb
(Figure S1) and between DCs and Mtb (Figure S2) during
infection process. Information regarding the nodes and edges of
TABLE 1 | Information regarding the nodes of the GWGEINs between Mφs
and Mtb and between DCs and Mtb.
Host- Host- Pathogen- Host- Pathogen-
miRNAs TFs TFs genes genes
Mφs vs. Mtb 23 82 92 9274 3070
DCs vs. Mtb 21 63 87 9827 3050
TABLE 2 | Information regarding the edges of the GWGEINs between Mφs
and Mtb and between DCs and Mtb.
Mφs vs. Mtb DCs vs. Mtb
Host-miRNA repressions of host-genes 387 44
Host-miRNA repressions of pathogen-genes 1 0
Host-TF regulations of host-genes 554 364
Pathogen-TF regulations of pathogen-genes 3468 3476
Host-TF and pathogen-protein interactions 45 24
Pathogen-TF and host-protein interactions 1 1
Host PPIs 78,502 101,452
Pathogen PPIs 5758 5783
Host-pathogen PPIs 1086 1169
GWGEINs are shown in Tables 1, 2, respectively. Since the host-
pathogen interaction process inMtb infection is very complex, it
is difficult to investigate the defensive mechanisms between host
and pathogen fromGWGEINs in Figures S1, S2. In this situation,
we applied the PNP method to the real cross-talk GWGEINs to
extract the principal network structures of the real networks.
Core Network Identification of the Real
Cross-Talk GWGEIN by Applying the PNP
Method
Before using the PNP method, it is necessary to construct
a combined network matrix H containing the estimated
parameters in the real cross-talk GWGEIN as follows:
H =


bˆ11 · · · bˆ1J dˆ11 · · · dˆ1M
... bˆjl
...
... dˆjm
...
bˆJ1 · · · bˆJJ dˆJ1 · · · dˆJM
dˆ11 · · · dˆ1J hˆ11 · · · hˆ1M
... dˆmj
...
... hˆmq
...
dˆM1 · · · dˆMJ hˆM1 · · · hˆMM
aˆ11 · · · aˆ1J 0 · · · 0
... aˆij
...
...
. . .
...
aˆJ1 · · · aˆJJ 0 · · · 0
0 · · · 0 eˆ11 · · · eˆ1M
...
. . .
...
... eˆnm
...
0 · · · 0 eˆM1 · · · eˆMM
−cˆ11 · · · −cˆJ1 −gˆ11 · · · −gˆM1
... −cˆik
...
... −gˆnk
...
−cˆ1K · · · −cˆJK −gˆ1K · · · −gˆMK


∈ R(2J + 2M + K) × (J + M)
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where aˆij and −cˆik were obtained in θˆ
HG
i estimated in (9) and
(22); bˆjl and dˆjm were obtained in θˆ
HP
j estimated in (13) and
(23); eˆnm and −gˆnk were obtained in θˆ
PG
n estimated in (17) and
(24); and hˆmq and dˆmj were obtained in θˆ
PP
m estimated in (21)
and (25). aˆij and eˆnm denote transcriptional regulatory abilities
in the intraspecies GRNs of host and pathogen, respectively; bˆjl
and hˆmq indicate interactive abilities in the intraspecies PPINs
of host and pathogen, respectively; −cˆik and −gˆnk represent
miRNA repression abilities in the intraspecies GRNs of host and
pathogen, respectively; and dˆjm and dˆmj signify the interactive
abilities between the jth host-protein and the mth pathogen-
protein in the interspecies PPIN between host and pathogen.
The estimated weights of the network connections in intraspecies
GRNs, intraspecies PPINs, and the interspecies PPIN therefore
consist the network matrixH of the real cross-talk GWGEIN. If a
connection does not exist in the candidate cross-talk GWGEIN
or has been pruned by AIC, the corresponding parameter in
network matrix H is zero. PNP is then applied to H to identify
the core network of the real cross-talk GWGEIN. PNP is based
on singular value decomposition of H as follows,
H = UDVT (26)
where UǫR(2J+2M+K)×(J+M); VǫR(J+M)×(J+M); and D = diag(d1,
..., ds, ..., dJ+M) consists of the J+M singular values of H in
descending order, i.e., d1 ≥...≥ds≥...≥ dJ+M . Note that, the
diag(d1, d2) denotes the diagonal matrix of d1 and d2. The
eigenexpression fraction (Es) is defined as follows,
Es =
d2s
J+M∑
s=1
d2s
(27)
We selected the top Q singular vectors of H with the minimal
Q such that
∑Q
s= 1 Es ≥ 0.85 which means that the Q principal
components contain 85% core network structure of GWGEIN
from the perspective of energy. The projection (T) of each row
in H to the top Q singular vectors V is defined as follows,
T(p, s) = hp × vs, for p = 1, ..., (2J + 2M + K)
and s = 1, ...,Q (28)
where hp and vs denote the pth row vector of H and the sth
column vector of V, respectively. We then defined the 2-norm
projection value of each node, i.e., gene/miRNA/protein, in the
real cross-talk GWGEIN to the core network structure consisted
of the top Q singular vectors as follows:
D(p) =
[∑Q
s=1
T(p, s)2
]1/2
, for p = 1, ..., (2J + 2M + K)
(29)
If D(p) is close to zero, the pth node is almost independent of the
core network structure consisted of the top Q singular vectors.
Because the purpose of the identification of the core network is
to investigate the offensive and defensive mechanisms between
host and pathogen from a perspective of signal transduction
pathways, the proteins with top D(p) from receptors to TFs
and their connected miRNAs and genes are chosen as the core
proteins/genes/miRNAs to consist the core network. Finally,
we extracted the HPCNs from the real cross-talk GWEGINs
between Mφs vs. Mtb and DCs vs. Mtb (Figures S3, S4),
respectively. Accordingly, HPCNs possess the principal structure
that represents the core GWGEINs duringMtb infection.
RESULTS AND DISCUSSION
GWGEINs of Mφs and DCs Infected with
Mtb
The GWGEINs of Mφs and DCs are shown in Figures S1, S2,
respectively. The number of nodes and edges are shown in
Tables 1, 2, respectively. There was no significant difference in
the number of nodes between Mφs and DCs. However, the edges
between both cell types in Table 2 demonstrated remarkable
difference in host-miRNAs to host-genes (DC:44, Mφ:387) and
host PPIs (DC:101452, Mφ:78502). The results show that there
are more miRNA regulations in Mφs than in DCs. Since more
genes are inhibited by miRNAs, it could result in that there
are less PPIs in Mφs than in DCs. Interestingly, the identified
PPIs between pathogen TFs and host proteins (i.e., Rv1423
negatively interacts with BNIP3L, −16 in Mφs and −27 in DCs)
present in both cell types indicate that Rv1423 may interfere with
BNIP3L, which is involved in the apoptosis in Mφs and DCs.
We also plotted the functional networks of GWGEINs in Mφs
and DCs (Figure 2). The number of genes participating in the
innate immune response, antigen processing and presentation,
cytokine production, and apoptosis was much higher in DCs
than in Mφs, suggesting that DCs are more responsive to the
infection of Mtb than Mφs. However, the GWGEINs did not
contain sufficient information for us to investigate the defensive
mechanisms between host and pathogen. Thus, we extracted
HPCNs from GWGEINs in both Mφs and DCs during earlyMtb
infection via the PNP method (Figures S3, S4).
HPCNs in Mφs and DCs Infected with Mtb
The Biological Processes of the Host Core Networks
in Both Cell Types
By using the PNP method, we extracted the HPCNs in Mφs and
DCs infected with Mtb as shown in Figures S3, S4, respectively.
In order to get an overview of the molecular mechanisms of the
host during infection, we used gene ontology (GO) to analyze
the biological processes of the host core networks in Mφs and
DCs. Furthermore, based on the PPIs of HPCNs, we constructed
the functional networks of HPCNs in Mφs and DCs as shown in
Figure 3.
The result indicates that the number of genes participating
in the innate immune response in DCs was higher than in
Mφs and the 110 innate immune response genes in DCs were
transcriptionally affected by 700 positive regulations and 653
negative regulations. In order to adapt to the infection of Mtb,
post-translation epigenetic modifications can be found inHPCNs
such as ubiquitination in Mφs and deacetylation in DCs. These
epigenetic modifications can be detected by the basal level of κj
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FIGURE 2 | The functional networks of GWGEINs in Mφs and DCs
during early Mtb infection. After constructing the GWGEINs of Mφs and
DCs during Mtb infection, we used gene ontology (GO) to analyze the
biological processes in both cell types. The number below each function
represents the gene number in GWGEINs that participate in the function. By
comparing the gene number of each function between Mφs and DCs, we
found that DCs are able to more effectively control Mtb infection than Mφs.
in the host protein expression model in (2). The host proteins
(IRF2 and SUMO1) in IFN-γ-mediated pathway, regulated
by the deacetylase protein (HDAC1), the SUMO proteins
(SUMO1, SUMO2, and SUMO3), and the ubiquitin proteins
(UBC and MUL1), and the host protein (UBC) in TLR signaling
pathway, regulated by the deacetylase protein (HDAC1),
the acetyltransferase protein (DLAT), the methyltransferase-
associated protein (MTAP), the SUMO proteins (SUMO1,
SUMO2, and SUMO3), and the ubiquitin proteins (UBC and
MUL1), present in DCs can activate the immune response. In
FIGURE 3 | The functional networks of HPCNs in Mφs and DCs during
early Mtb infection. We used gene ontology (GO) to analyze the biological
processes of host-pathogen core networks (HPCNs) in Mφs and DCs during
Mtb infection. The gene number participating in cell growth in Mφs is higher
than in DCs, whereas the gene number participating in apoptosis in DCs is
higher than Mφs. Thus, DCs tend to undergo apoptosis, and can avoid the
influence from Mtb, whereas Mφs tend to go into cell growth and can be easily
influenced by Mtb. Protein ubiquitination and ion homeostasis are only present
in Mφs, which are required for Mφs to adapt to the rapid changes during
infection. The IFN-γ-mediated and toll-like receptor (TLR) signaling pathways
are only present in DCs. In addition, protein deacetylation in DCs may protect
DCs from the Mtb infectious mechanisms.
addition, the host proteins (AP3D1, ATG5, and PTPRC) in ion
homeostasis, regulated by the ubiquitin protein (UBC) and the
SUMO protein (SUMO2), are induced in Mφs to counteract
the increase in metal ions during infection. Mφs can induce
apoptosis during infection but Mtb can block this process. The
number of cell growth-related genes was higher than those
related to apoptosis (Figure 3), which facilitates the survival
of Mtb in Mφs. However, in DCs, there were more apoptotic
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genes than cell growth genes. Additionally, in Mφs, two pro-
apoptotic proteins (MOAP1, and APAF1) were involved in
apoptosis, while, in DCs, three pro-apoptotic proteins (BCL2,
CFLAR, and AIFM1) and one anti-apoptotic protein (XIAP)
were involved in apoptosis. We further identified that the host
protein SKP1, involved in the innate immune response, positively
regulates the pro-apoptotic proteins in DCs. This indicates
that DCs are less susceptible than Mφs and readily induce
apoptosis mediated by the innate immune response as a means of
eliminatingMtb.
Host-Pathogen Cross-Talk Interactions in Both Cell
Types
The cross-talk between pathogen and host has been widely
investigated. However, the real genetic and epigenetic network
connections and host-pathogen PPIs are still unclear. Here, we
compared HPCNs to show the common and different cross-
talk interactions between Mφs and DCs during Mtb infection
(Figure 4). It has shown that 126 Mtb genes found by the
analysis of transposon mutant pools to be required for survival
are constitutively expressed rather than regulated at least in
primarymouseMφs (Rengarajan et al., 2005). SevenMtb proteins
(Rv1049, Rv1681, Rv1337, Rv3868, Rv0928, Rv3283, and Rv3269)
of the HPCN in Mφs infected with Mtb (Figure S3) and three
Mtb proteins (Rv1049, Rv0082, and Rv3369) of the HPCN in DCs
infected withMtb (Figure S4), encoded by theMtb genes required
for the survival ofMtb in host, have been identified in this study.
Additionally, by identifying mutations that alter the phenotypic
consequence (i.e., genetic interactions) of inactivating a gene of
interest, 66 Mtb genes that encode the proteins which associate
to form multisubunit transporters required for Mtb survival in
the host have also been found (Joshi et al., 2006). Two Mtb
proteins (Rv2004c, and Rv3877) of the HPCN in Mφs infected
withMtb (Figure S3) and anMtb protein (Rv0427c) of the HPCN
in DCs infected with Mtb (Figure S4), encoded by the Mtb
genes involved in transporter assembly required forMtb survival
in host, have been also identified in this study. However, the
comparison between two HPCNs in Mφs and DCs infected with
Mtb (Figure 4) does not contain any essential Mtb gene/protein
required for the survival ofMtb in host. The comparison result in
Figure 4 comprises 11 differentially expressed pathogen proteins
and 17 non-differentially expressed pathogen proteins between
two host cells. It is because the result in Figure 4 contains the
proteins or genes, which have themost differential interactions or
regulations between two HPCNs in Mφs and DCs infected with
Mtb. It intuitively indicates that theMtb essential genes/proteins
were involved in the HPCNs in Mφs and DCs infected withMtb
to respectively assist the different mechanisms between Mφs and
DCs infected withMtb from a perspective of signal transduction
pathway.
In Figure 4, there are three pathogen proteins (Rv0667,
Rv0762c, and Rv1438) interacting with host proteins (UBC,
EGFR). In addition, there are other pathogen proteins (Rv2404c,
Rv1696, and Rv1098c) that may help Rv0667, Rv0762c, and
Rv1438 promote host-pathogen interactions. This suggests that
Mφs are more easily influenced by Mtb than DCs during
early infection, and therefore specific interactions are present
only in Mφs. Moreover, Rv2404c, Rv1696, and Rv1098c (their
expression was significantly activated in Mφs (p < 0.05) rather
than in DCs) promote cross-talk interactions in Mφs, inducing
the influence on Mφ invasion. In addition, Rv2404c, Rv0667,
Rv0762c, Rv1098c, Rv1696, and Rv1438 are localized on the
cell wall. This is consistent with the pathogenesis of Mtb in
which membrane proteins influence the host immune response
and enhance pathogen survival ability. The host protein UBC
associates with the toll-like receptor-signaling pathway. We
identified that the host protein UBC is negatively affected by
the pathogen via Rv0667, Rv0762c, and Rv1438 Mφs, while it is
positively affected by the pathogen Rv1438 in DCs. Therefore,
Mtb can alter the host immune system in both Mφs and DCs by
binding to UBC. In addition, UBC plays a role in phagocytosis
as well as antigen processing and presentation processing (Peters
et al., 1998). Accordingly,Mtb avoids the host antigen processing
and presentation processing by binding to UBC in both Mφs and
DCs. Although, Mtb affects UBC in both cell types, the three
negative interactions of UBC by pathogen in Mφs result in more
influence on the immune system and antigen presentation than
in DCs. This accounts for why Mφs are more susceptible toMtb
than DCs.
EGFR (epidermal growth factor receptor) is involved in cell
growth. Pathogen protein Rv1438 interacts with EGFR in both
Mφs and DCs, and affects the process of cell growth (Figure 4).
By doing this, Mtb can survive in host cells without being killed
by the apoptosis process. Because Mtb promotes cell growth, a
recent study has shown that the inhibition of EGFR could restrict
the growth of Mtb (Stanley et al., 2014). Furthermore, EGFR is
also involved in the MAPK signaling pathway, which transducts
extracellular signals from receptors on the membrane to the
DNA in the nucleus of the cell. We identified that the oxidative
stress responsive proteins (OXSR1, and OSGIN1) are negatively
affected by UBC in Mφs. Moreover, it has been proposed that
Helicobacter pylori infection induces oxidative stress (Ding et al.,
2007), which could increase the DNAmutation risk by inhibiting
oxidative stress responsive proteins (McAdam et al., 2016). The
interaction of the pathogen protein, Rv1438, may cause the
dysregulated EGFR in Mφs and influence the MAPK signaling
pathway. Although Rv1438 interacts with EGFR during Mtb
infection of Mφs and DCs, the expression of Rv1438 is higher
inMtb and the oxidative stress responsive proteins (OXSR1, and
OSGIN1) are negatively affected by UBC, infecting Mφs, and
causing more reactive intermediates that could lead to mutations
in macrophages during infection in Mφs during Mtb infection.
EGFR is not only associated with cell growth but is also involved
in the PI3K-Akt signaling pathway, which plays a role in the
signal transduction pathways of cytokines. Rv1438 can interrupt
the immune response, causing a delay in inflammation, thus
expediting the invasion ofMtb during early infection. In addition,
it has been reported that Rv1438 is an essential gene for in
vitro growth of Mtb H37Rv (Griffin et al., 2011). Taken together,
Rv1438 can induce EGFR dysregulation through the interspecies
interaction between them, which interrupts antigen presentation
via UBC. Due to its participation in several cellular functions
in the host, Rv1438 could be a potential drug target for future
treatment of tuberculosis.
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FIGURE 4 | Comparison of the HPCNs in Mφs and DCs infected with Mtb during early infection. Host-pathogen core networks (HPCNs) contain the major
structure of GWGEINs via the principal network projection (PNP) method, which allowed investigation of the underlying mechanisms of the host and pathogen. HPCNs
highlight the different signaling pathways between Mφs and DCs duringMtb infection. The upper half shows the pathogen network and the lower half the host network.
The edges with solid black lines represent presence in both cell types. The names in red, blue, and black represent the proteins specific in Mφs, DCs, and both cell
types, respectively. We denote the lightning bolts to represent proteins with epigenetic modifications due to the significant basal level changes between Mφs and DCs.
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Host Responses in Mφs and DCs during Mtb
Infection
Human cells possess the ability to change the behavior of proteins
in order to adapt to rapidly changing circumstance. This is
referred to as epigenetics or post-translational modifications,
which include methylation, sumoylation, ubiquitination, and
acetylation. The epigenetic influence on proteins is more efficient
than the genetic influence on DNA transcription for adaptation
to the changing environment during infection.
In both cell types, there are proteins implicated in
ubiquitination such as UBC and CUL3, deacetylation such
as HDAC1 and SIRT7, and sumoylation such as SUMO1,
SUMO2, and SUMO3 (Figure 4). Ubiquitination can affect
proteins in many ways such as inducing degradation via the
proteasome, and altering their cellular location. As shown in
Figure 4, UBC has edges that are more specific in Mφs than
they are in DCs, and CUL3 participates in DCs more than in
Mφs. In addition, the expression of HDAC1 is higher in DCs,
and there are differential basal levels of UBC between Mφs and
DCs. This indicates that HDAC1 has higher activity in Mφs and
may affect UBC, which is involved in several immune responses
through deacetylation, which results in a change in basal levels.
Furthermore, it has been reported that HDAC inhibitors induce
inhibition of the host immune response against microbial
pathogens in Mφs and DCs (Roger et al., 2011). Specifically,
HDAC functions such as histone deacetylation enhance the
immune response in Mφs against bacterial infection. UBC may
be affected by not only deacetylation but also by sumoylation.
In addition, the proteins ELAVL1 and SUMO1/2/3 may be
influenced by deacetylation via their interaction with HDAC1.
Oxidative stress is a reflection of the imbalance between
reactive oxygen species (ROS) and the biological system’s ability
to detoxify the reactive intermediates or to repair the resulting
damages. High ROS production and disturbances in normal
redox state lead to oxidative stress. Oxidative stress is a primary
response of the immune system, and the induction of ROS
during infection helps the immune system to kill pathogens.
However, the simultaneous production of ROS and free radicals
damages cellular components, including proteins, lipids, and
DNA. Amyloid precursor protein (APP) is involved in the
response to oxidative stress, and the APP receptor receives
oxidative stress signals induced by the immune system during
Mtb infection. The higher APP expression in Mφs than in DCs
demonstrates that there is more oxidative stress in Mφs. The
high ROS production not only helps the host kill the pathogen
but also causes DNA damage, and therefore the host cell must
typically inhibit ROS production. The tyrosine kinase SYK also
plays a role in ROS production (Romero et al., 2014). High
expression of APP in Mφs reflects the high oxidative stress
(Figure 5A). Accordingly, APP can signal via SYK to induce ROS
production. mir-224 has been characterized as an inhibitor of
ROS production through silencing SYK, but the low expression
of mir-224 in Mφs demonstrates that Mφs still need SYK to
produce ROS. Inhibition of the over production of ROS is
only observed in Mφs, emphasizing the difference in defense
mechanisms between Mφs and DCs. Specifically, Mφs prioritize
killing the pathogen, whereas DCs prioritize antigen presentation
to activate an adaptive immune response. The deacetylation of
UBC may enhance the downstream immune response to protect
the host from the invasion of Mtb. However, pathogen proteins
Rv0667, Rv0762c, and Rv1438 may interfere with the production
of SYK through interacting with UBC to prevent ROS mediated
elimination of the pathogen.
CD84, a member of the signaling lymphocyte activation
molecule (SLAM) family modulates several immune responses,
including T cell/B cell activation and antibody production
(Figure 5A). CD84 is a hemophilic receptor expressed on T cells,
B cells, DCs, monocytes, and Mφs. The expression of CD84
increases the activation of T cells, B cells, and DCs. SYK is
also involved in the adaptive immune response. CD84 affects
SYK through interacting with UBC in Mφs, thus modulating the
adaptive immune response. This is a mechanism employed by
Mφs to activate the adaptive immune response during infection.
However, activation of adaptive immunity can be blocked by
the pathogen via the interaction of UBC to prevent antibody
production and promote its survival.
Other differences in the response to oxidative stress initiated
in Mφs and DCs were also identified. RPL13A plays a role in
ubiquitination and assists ETS1 in its translocation to the nucleus
for transcription (Figure 5B). The PMS2P1 gene is regulated by
ETS1 in Mφs and DCs. The high expression of PMS2P1 in Mφs
could be due to the high activity of ETS1. The main function
of PMS2P1 is to repair DNA damage caused by oxidative stress.
Therefore, the high expression of PMS2P1 indicates that there
is more oxidative stress in Mφs, which is required for DNA
repair. Mtb proteins could also account for the high expression
of PMS2P1 in Mφs. PMS2P1 can induce deacetylation to control
its activity (Edwards et al., 2009); however, Mtb proteins can
counteract this process, causing high expression of PMS2P1.
High DNA repair activity is an important mechanism of cancer
progression. In addition, ETS1 can function as an oncogene and
drive tumorigenesis (Kathuria et al., 2011). The high expression
of ETS1 and PMS2P1 as well as the influence from Mtb proteins
may play a role in the progression fromTB to lung cancer inMφs.
PRKAR1A encodes the type 1α regulatory subunit (RIα)
of cAMP-dependent protein kinase (PKA). The RIα protein is
upregulated in many cancer cell lines, suggesting its potential
role in cell cycle regulation and growth. It has been shown
that the overexpression of RIα in lung cancer (Young et al.,
1995) is indicative of growth of lung cancer cells. EGFR
methylation negatively regulates the EGFR downstream pathway
(Montero et al., 2006). However, Mtb proteins can affect
PRKAR1A function by interacting with EGFR and UBC despite
of the methylation of EGFR and ubiquitination of PRKAR1A
(Figure 5C; Gu et al., 2015). The significant change (p < 5.67
× 10−14) in the gene expression profiles of EGFR between Mtb-
infected Mφs and DCs supports this finding. PRKAR1A has
higher expression in Mφs than in DCs, which may cause cell
growth in Mφs. Cell growth benefits the survival of pathogen.
Pathogen proteins such as Rv0667, Rv1438, and Rv0762c may
interfere with the activity of PRKAR1A by interacting with
UBC. The higher expression in Mφs than DCs results from the
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FIGURE 5 | The signaling pathways of the host molecular mechanisms based on HPCNs in Figure 4 in Mφs and DCs during Mtb infection. (A) Reactive
oxygen species (ROS) production is present only in Mφs and may be influenced by Mtb proteins through interaction with UBC. In addition, CD84 signals to SYK to
activate lymphocytes through UBC. Deacetylation of UBC avoids the influence from Mtb proteins. (B) The high activity of DNA repair in Mφs reflects DNA damage
caused by oxidative stress in Mφs, and is dysregulated by Mtb proteins in spite of the deacetylation of PMS2P1. (C) The induction of cell growth in Mφs may be
influenced by Mtb proteins through interaction with UBC despite ubiquitination of PRKAR1A and EGFR methylation. DCs avoid cell growth through the inhibition of
mir-612 and mir-636. (D) Differential regulation of RPS10, which is involved in cell growth in both cell types, may be influenced by Mtb proteins through interaction with
UBC. Although, RPS10 induces ubiquitination in Mφs, Mtb proteins can influence RPS10 by inducing its activity in both cell types. (E) High expression of PFDN5 in
Mφs indicates that Mφs tend to correct unfolded or misfolded proteins, whereas PFDN5 is inhibited by mir-224 in DCs. The accumulation of unfolded or misfolded
proteins and antigens in DCs leads to formation of the dendritic cell aggresome-like induced structures (DALIS) to delay degradation via the proteasome at an early
stage of maturation, until during the late stage maturation of DCs.
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inhibition of mir-612. The high expression of mir-612 and mir-
636 in DCs inhibits PRKAR1A expression, whereas PRKAR1A
is highly expressed in Mφs due to low mir-612 and mir-636
expression in this cell type. This suggests that DCs are able to
avoid dysregulation of cell growth caused by the pathogen, which
indirectly reduces the ability ofMtb to residue in DCs.
Ribosomal protein S10 (RPS10) is also associated with cell
growth, as it plays a critical role in ribosome biogenesis (Ren et al.,
2010). RPS10 is regulated by TFs (YBX1, SREBF1, and ETS1)
in both Mφs and DCs (Figure 5D). Ubiquitination of RPS10
interferes with its activity, which is associated with cell growth in
Mφs (Buckley et al., 2012). However, the function of RPS10 can
indirectly be blocked by Mtb proteins through interaction with
UBC, as a means of controlling cell growth in Mφs.
Ubiquitination of YBX1 facilitates its transport from the
cytosol to the nucleus for transcriptional regulation. In
Figure 5E, PFDN5 is regulated by YBX1 and mir-224, but mir-
224 is expressed at higher levels in DCs than it is in Mφs,
causing higher expression of PFDN5 in Mφs. The decreased
expression of PFDN5, which plays a role in protein folding,
and the oxidative stress in DCs could result in the induction of
misfolded proteins. For the maintenance of cellular homeostasis,
misfolded proteins must be ubiquitinated for degradation via
the ubiquitin-proteasome pathway. It has been reported that
ubiquitinated misfolded proteins can accumulate in DCs to
form dendritic cell aggresome-like induced structures (DALIS),
and the ubiquitinated proteins in DALIS are protected from
degradation via the proteasome during the early stages of
DC maturation (Lelouard et al., 2002). At the late stage of
maturation, the proteasome actively participates in the removal
of DALIS (Lelouard et al., 2002). In addition, DALIS act as
an Ag (antigen of Mtb) storage center during DC maturation
to prioritize degradation of proteins in response to infection
(Canadien et al., 2005). Taken together, the formation of DALIS
helps DCs promote antigen processing during DCmaturation for
presentation of the peptides on MHCmolecules to B cells.
The Protective Mechanisms of Mtb in Mφs and DCs
Rv0667 (RpoB), a DNA-directed RNA polymerase that catalyzes
the transcription of DNA to RNA, plays an important role in
Mtb infection. There are many PPIs of Mtb that interact with
Rv0667 in Mtb, infecting Mφs and DCs (Figure 4). Rv0667 is
highly expressed in Mtb, infecting Mφs, and it interferes with
the function of the host protein UBC to facilitate Mtb invasion
(Figure 6A). In addition, high expression of Rv1438, Rv1098c,
and Rv2404c increases the activity of Rv0667 in Mφs. Because of
its role inMtb infection, RpoB is the target of the drug rifampicin
and also plays a role during infection. Mutations are spontaneous
and then selected under drug selection pressure. Possibly, DNA
damage could increase the mutation rate overall.
The function of Rv0762c is currently unknown. It has been
suggested that Rv0762c functions in fatty acid metabolism as an
additional bacterial adaptation for Mtb to survive novel host-
derived pressures within the phagosomal environment (Rohde
et al., 2012). As shown in Figure 6A, Rv0762c may influence
the host gene RPS10, which is involved in the cellular metabolic
process via its interaction with UBC and ETS1 in Mφs. Another
metabolic enzyme, Rv1438 (TpiA), triosephosphate isomerase, is
an essential enzyme for gluconeogenesis and glycolysis, and is
essential for the survival ofMtb (Connor et al., 2011). The varying
basal expression levels of Rv1438 may result from acetylation
(Kuhn et al., 2014), which can enhance its interaction with host
proteins. For example, Rv1438 interacts with EGFR and UBC
in Mφs and DCs (Figure 6A). Rv1438 may also influence host
defense mechanisms through EGFR and UBC in both cell types.
Copper (Cu) is an essential element for the growth and
development of most organisms, including bacteria. It has been
shown that Cu in Mtb binds to various enzymes including
cytochrome c oxidase and Cu/Zn superoxide dismutase. In
addition, Cu helps Mtb resist oxidative stress (Piddington et al.,
2001), suggesting that Cu is essential for Mtb survival. However,
overload of Cu in most systems is toxic. A study reported that the
concentration of Cu is dramatically increased in phagolysosomes
of mouse Mφs after infection with severalMycobacterium species
(Wagner et al., 2005). Another study demonstrated that guinea
pigs responded to Mtb infection by increasing Cu concentration
in the lung lesions, and this coincides with a reduction in
bacterial burden (Wolschendorf et al., 2011). These findings
demonstrate that Cu is used by the host immune system to
control Mtb infection, and Mtb evolves Cu homeostasis as a
protective mechanism. The rv0969 (ctpV) gene is part of a Cu-
induced operon, and encodes a Cu-specific inner membrane
eﬄux pump that transports excess Cu out of Mtb in order to
prevent toxicity. In order to maintain Cu homeostasis in Mtb,
it is possible that the bacteria has a repressor of Rv0969 in the
absence of Cu. Rv0967 (CosR) represses the expression of cso
(copper sensitive operon) and induces Cu in Mtb (Ward et al.,
2008). As shown in Figure 6B, Rv0967 and Rv0969 are similarly
expressed in Mφs and DCs. This suggests that there may have
been Cu homeostasis of Mtb during infection in both cell types.
Rv0970 is an integral membrane protein, but its main function
is currently unknown. The rv0970 gene is regulated by several
TFs in both cell types, specifically Rv0324 and Rv1423 in DCs and
Rv0081 and Rv2324 in Mφs, causing Rv0970 with no significant
differential expression. This indicates that there are different
regulatory functions of Rv0970 in Mφs and DCs. In addition,
Rv0970 interacts with Rv0967 and Rv1969 in both cell types,
and may participate in Cu homeostasis. Thus, Rv0970 probably
plays an important role in Cu homeostasis in both cell types, and
controls different responses to different circumstances in Mφs
and DCs.
The interaction between bacteria–host occurs since their
evolutionary origin and these mechanisms were implied in the
evolution of the human (their homeostasis or their immune
system). Most of bacteria that live with and within the human
are part of the superorganism. There are different mechanisms
employed by the host to limit the growth ofMtb such as nutrient
and oxygen limitation, acidic pH, and formation of reactive
oxygen/nitrogen intermediates, which forces Mtb to become
dormant. Rv0081 is upregulated in multiple latency models,
and is shown to be regulated by dormancy survival regulator
(DosR) (Balázsi et al., 2008). DosR is essential for survival ofMtb
during anaerobic dormancy, which mediates entrance into and
throughout the dormant state (Leistikow et al., 2010). Another
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FIGURE 6 | The signaling pathways of pathogen protective mechanisms based on HPCNs in Figure 4 in Mφs and DCs during Mtb infection. (A) The
proteins Rv0667, Rv1696, Rv2404c, Rv0762c, Rv1438, and Rv1098c are expressed on the cell membrane of Mtb, and Rv0667 and Rv1438 are essential for the
survival of Mtb. These proteins may counteract the defensive mechanisms of both cell types through interactions with EGFR and UBC. Therefore, these proteins with
higher expression and more specific edges in Mφs than DCs could cause the dysfunction of cell growth and DNA repair in Mφs. Some of these proteins have
differential basal levels, whereas only Rv1438 has been found to undergo acetylation, which could facilitate its interaction with host proteins. (B) The metal-dependent
homeostasis signaling pathway plays an important protective role to counteract the defense mechanisms of host cells. However, the metal-dependent homeostasis
signaling pathway of Mtb varies between Mφs and DCs. Mtb evolves this pathway to counteract the metal burst from host cells and induce metal homeostasis in Mφs
and DCs during infection. The function of Rv0970 is still unknown, whereas rv0970 is regulated by different transcription factors (TFs) of Mtb in Mφs and DCs, and
interacts with Rv0967 and Rv0969 after translation, a member of the metal-dependent homeostasis signaling pathway. Rv1675c regulates itself and interacts with
metal-dependent proteins or TFs in Mφs. Furthermore, Rv1675c is highly expressed and demonstrates specific edges in Mφs, which plays an important role in the
metal-dependent homeostasis signaling pathway in Mφs. The inhibition of mir-636 on rv0353 in Mφs could decrease antibody production.
study demonstrated that the control of bacterial replication in
latency in mice requires IFN-γ, TNF-α, and nitric oxide (NO)
(Voskuil et al., 2003). Furthermore, the expression of Rv0081
could induce Mtb exposure to NO. These studies suggest that
Rv0081 may play an important role in the dormancy of Mtb.
However, the mechanism is not demonstrated in our HPCNs
because at the 18 h time point, granulomas have not yet formed
in Mφs. Rv0081 has another role as a member of the ArsR/SmtB
family of metal-dependent transcriptional regulators. As such,
it functions as a regulator of metal homeostasis of Mtb for
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preventing metal stress within the host (Campbell et al., 2007).
As shown in Figure 6B, Rv0081 has more specific PPI edges and
regulatory genes in Mφs, which could suggest that Rv0081 acts as
a metal-dependent transcriptional regulator of Mtb specifically
within Mφs. Another TF, Rv0324, with an N-terminal HTH
ArsR-type DNA-binding domain, may act as an ArsR metal-
dependent transcriptional regulator (Li et al., 2015). Rv0324 has
more specific PPI edges and regulatory genes inDCs, which could
suggest that Rv0324 acts as a metal-dependent transcriptional
regulator of Mtb specifically within DCs (Figure 6B). Thus, Mtb
utilizes a different metal-dependent homeostasis pathway within
the two cell types, which may result from the adaptive response
that allowsMtb to survive in different circumstances.
Rv2234 (PtpA), a protein tyrosine phosphatase, has been
shown to be an essential enzyme for the survival of Mtb in
Mφs (Koul et al., 2000). Furthermore, NO and ROS have been
shown to reduce Rv2234 activity in Mφs, and this disrupts the
growth ofMtb in Mφs (Ecco et al., 2010). In Figure 6B, the high
expression of Rv2234 in Mφs is not inhibited by NO or ROS. We
also show that Rv2234 interacts with Rv0081 and Rv0324, which
are both metal-dependent transcriptional regulators in Mφs and
DCs, respectively. This suggests that Rv2234 may be involved in
the metal-dependent pathway in both cell types.
Rv1173 (FbiC) is essential for F420 production, and
participates in the F420 biosynthetic pathway (Choi et al.,
2002). F420 is catalyzed by F420-dependent glucose-6-phosphate
dehydrogenase into H2F420 (Purwantini et al., 1997). One
mechanism for host killing of Mtb is through phagosome
acidification. The induction of NO in acidified phagosomes
during activation of Mφs, leads to its conversion to NO2. Mtb is
more sensitive to NO2 than to NO under aerobic conditions, and
has evolved a mechanism to decrease the antibacterial action of
Mφs by converting NO2 back to NO via H2F420 (Purwantini and
Mukhopadhyay, 2009). Although NO is known to killMtb under
both aerobic and hypoxic conditions, NO2 is more toxic than
NO under aerobic conditions (Purwantini and Mukhopadhyay,
2009). The high expression of Rv1173 in Mtb in Mφs compared
to DCs, indicates greater nitrosative stress in Mφs (Figure 4).
The induction of Rv1173 increases the production of H2F420 to
convert NO2 to NO for protectingMtb from the nitrosative burst
in Mφs under aerobic conditions.
Rv1675c (Cmr) is a CRP/FNR family transcription factor
that is expressed in response to cAMP levels (McCue et al.,
2000). cAMP is a common second messenger molecule that
plays an important role in catabolite repression, virulence, and
signaling pathways in many bacterial pathogens including Mtb
(McDonough and Rodriguez, 2012). During Mφ infection, Mtb
produces a cAMP burst within Mφs to promote the survival
of Mtb (Agarwal et al., 2009). In Figure 6B, high expression
of Rv1675c in Mφs reflects the high cAMP levels within Mφs.
Furthermore, Rv1675c interacts with many proteins, and has
more specific edges inMφs than DCs. Rv1675c also interacts with
three metal-dependent proteins Rv0081, Rv0324, and Rv0967
as previously mentioned. This indicates that Rv1675c may
participate in the metal-dependent pathway that facilitates Mtb
resistance to the induction of metal toxicity within Mφs during
early infection, although this has not yet been demonstrated.
A recent study reported that Rv1675c regulates rv1675c,
and is involved in Cmr-mediated gene regulation (Figure 6B;
Ranganathan et al., 2015). In addition, the interaction of
Rv1675c with Rv0667 may indirectly influence the host in HPCN
(Figure 4). Altogether, Rv1675c may participate in Mtb host
manipulation through Rv0667, and plays a role in protectingMtb
frommetal toxicity by interaction withmetal-dependent proteins
in Mφs. This suggests that Rv1675c is essential for Mtb survival
during early infection in Mφs, and could be a potential drug
target.
Rv0353 is an Mtb antigen that can be processed and
presented on MHC molecules, which promotes the production
of antibodies against Mtb. It has been shown that Rv0353 favors
the activation of DCs during early Mtb infection (Gupta et al.,
2010). However, mir-636 inhibits rv0353 in Mφs (Figure 6B).
In addition, the antigen processing capacity of Mφs is reduced
by Mtb proteins, causing a reduction in antibody production.
In contrast, DCs can still process Rv0353 and present it on
MHC molecules. Thus, repression of mir-636 and the Mtb
membrane proteins, shown in Figure 6A, may recover the
antigen processing capacity of Mφs and increase the production
of antibodies. In addition, Rv0353 also interacts with metal-
dependent TFs including Rv0081 and Rv0324 (Figure 6B),
indicating the participation of Rv0353 in metal-dependent
homeostasis signaling pathways in both cell types.
Overview of the Defensive Mechanisms of the Host
and Pathogen and the Dysfunctions of the Host in
Mφs and DCs
Figure 7 provides an overview of the previously mentioned
defensemechanisms inMφs andDCs. The diagramdemonstrates
that the same mechanisms employed by both cell types have
different activity because of the influence fromMtb or as a result
of miRNA inhibition.
First, we discuss the host mechanisms and the defensive Mtb
proteins to counteract these host mechanisms. SYK is involved
in ROS production, and is present only in Mφs. It acts as an
immune response in Mφs to eliminate Mtb. However, SYK can
be influenced by Mtb proteins, indicating that Mtb can interfere
with ROS production in Mφs. Another defense mechanism for
host cells is metal toxicity, which is utilized by both cell types.
However, Mtb evolves metal-dependent homeostasis signaling
pathway to counteract the metal toxicity in both cell types.
The defensive mechanisms of the host can be counteracted
by Mtb, causing dysfunction of host cells. PMS2P1 functions
in DNA repair with its high expression in Mφs, and can be
influenced by Mtb proteins, causing DNA repair dysfunction
in Mφs. PRKAR1A is involved in cell growth and is highly
expressed in Mφs. Its expression is reduced in DCs because of
mir-612 and mir-636 inhibition, which suggests that Mtb can
easily dysregulate cell growth in Mφs. RPS10 is also involved in
cell growth, is present in both cell types, and can be influenced
by Mtb proteins in both cell types. PFDN5 functions to correct
unfolded or misfolded proteins. It is highly expressed in Mφs
and poorly expressed in DCs because of mir-224 inhibition.
Without inhibition of PFDN5 by miRNA in Mφs, the correction
of unfolded or misfolded proteins would be constitutively active
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FIGURE 7 | The defensive mechanisms of the host and pathogen and the dysfunction of the host in Mφs and DCs during early Mtb infection. The upper
figure summarizes the defensive mechanisms of the host in Mφs during early Mtb infection. The defensive proteins (Rv1438, Rv0762c, and Rv0667) and
metal-dependent homeostasis signaling pathway of Mtb within Mφs counteract the host defense mechanisms. The lower figure summarizes the defensive
mechanisms of the host in DCs during early Mtb infection. The defensive proteins (Rv1438, Rv0762c, and Rv0667) and metal-dependent homeostasis signaling
pathway of Mtb within DCs influence host defense mechanisms. We observed that the defensive mechanisms of Mφs are more easily influenced by Mtb than DCs,
indicating that Mφs are more susceptible to Mtb than DCs. In addition, the dysfunction in Mφs such as DNA repair and cell growth caused by Mtb may easily cause
the accumulation of mutations in Mφs. Thus, Mtb infection of Mφs may promote progression from TB to lung cancer.
in Mφs, which could contribute to progression from TB to cancer
in Mφs. UBC is involved in antigen processing and presentation,
and can be influenced by Mtb proteins in both cell types. There
are more Mtb proteins to interfere with UBC in Mφs, which
suggests that DCs are able to induce more antigen processing
and presentation than Mφs. Mtb induces cellular dysfunctions
in DNA repair and cell growth in Mφs. This suggests that Mtb-
infected epithelial cells may have similar dysfunctions in DNA
repair and cell growth, which may contribute to the progression
of lung cancer.
Drug Targets, Drug Mining and
Multi-Molecule Drug design
Amajor preventative agent against TB is Bacille Calmette-Guérin
(BCG), an attenuated vaccine strain extracted from ox infected
with M. bovis by Calmette and Guérin. Bacille Calmette-Guérin
vaccination is typically administered at birth, and is highly
effective in preventing the development of TB. However, BCG
efficacy decreases over time, and the protection in adults is not
as effective as in children (Andersen and Doherty, 2005). Some
studies have shown that BCG protects humans for only 10–20
years (Comstock et al., 1976; Hart and Sutherland, 1977; Sterne
et al., 1998). Although several new drugs have been developed
and are successful against tuberculosis, the development of
multi-drug resistance tuberculosis (MDR-TB) and extensive drug
resistance tuberculosis (XDR-TB) limit their efficacy (Johnson
et al., 2006; Alexander and De, 2007). MDR-TB is resistant to
isoniazid and rifampicin, which are the two most effective anti-
TB drugs (Zignol et al., 2012). XDR-TB is also resistant to these
as well as second-line drugs (Centers for Disease Control and
Prevention, 2006).
Because of its important role in the defense against Mtb
infection inMφs, we predicted Rv1675c as a potential drug target.
Inhibition of Rv1675c may interfere with auto-regulation and
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the metal-dependent pathways of Mtb in Mφs. Moreover, the
cell wall or cell membrane proteins Rv1098c, Rv0967, Rv0667,
Rv1696, and Rv2404c have been identified using automated two-
dimensional, capillary high-performance liquid chromatography
(LC) coupled with mass spectrometry (MS) (2DLC/MS) in
TubercuList (Mawuenyega et al., 2005). In TubercuList, Rv1098c,
and Rv0667 have been also identified as essential genes by
Himar1-based transposon mutagenesis in H37Rv strain (Sassetti
et al., 2003) while Rv1696 is required for growth in C57BL/6J
mouse spleen, by transposon site hybridization (TraSH) in
H37Rv (Sassetti and Rubin, 2003). However, in TubercuList,
Rv0967 and Rv2404c have been identified as non-essential
genes by Himar1-based transposon mutagenesis in H37Rv strain
(Sassetti et al., 2003), and non-essential genes for in vitro
growth of H37Rv, by sequencing of Himar1-based transposon
mutagenesis (Griffin et al., 2011). Therefore, we suggested that
Rv1098c, Rv0667, and Rv1696 are important for the survival
of Mtb in both cell types and can be easily targeted by drugs.
Because we have identified that the pathogen TF Rv0081 is
positively affected by Rv0969 during the Mtb infection of Mφs,
the pathogen TFs Rv0081 and Rv0324 could be positively affected
by Rv0969 during the Mtb infection of DCs. When Rv0969 is
targeted by the proposed drugs, the expression levels of the
pathogen proteins Rv1675c and Rv0970 could be attenuated
during theMtb infection of Mφs and DCs (Figure 6). Therefore,
the inhibition of drug targets Rv0967, Rv0969, and Rv0970 could
lead to the inhibitive combination of Cu homeostasis during
the Mtb infection of Mφs and DCs. These proteins may also
become potential drug targets for multi-molecule drug design
for future therapy of Mtb infection. The repression of mir-636
and Mtb membrane proteins may help Mφs increase antibody
production. However, there is currently no drug to inhibit
mir-636.
After predicting potential multiple drug targets, we then
designed a potential multi-molecule drug for targeting these
potential multiple drug targets through drug mining from
literature review. To date, a drug database for drugs targeting
Mtb proteins has not been constructed, so we explored studies
predicting that some drugs may inhibit potential multiple drug
targets. A study based on the comparison of binding sites
of existing drugs for human use against the entire structural
proteome of the pathogen predicted Lopinavir as a drug against
the Mtb protein Rv1438 (TpiA) (Kinnings et al., 2010). Another
study reported that TMC207 targets heavy metal P-type ATPases
including Rv0969 (CtpV) (Andries et al., 2005; Novoa-Aponte
and Soto Ospina, 2014), which may mediate Mtb P-type ATPase
activation and enhance the metal toxicity to eliminate Mtb
during metal burst in Mφs and DCs. In addition, copper-
boosting compounds ATSM and GTSM have been reported
to increase the Cu level in Mtb rather than disrupting Cu
homeostasis (Speer et al., 2013). Finally, we combine these
drugs to generate potential multi-molecule drug as shown in
Figure S5 for the potential multiple drug targets, which could
be efficient for the treatment of Mtb infection in both cell
types. The present drug molecule Lopinavir was predicted to
target the Mtb protein Rv1438 (TpiA), which interrupts the
interactions between Rv1438 and host proteins (Kinnings et al.,
2010). Another study reported that the molecule TMC207 targets
heavy metal P-type ATPase including Rv0969 (CtpV) (Andries
et al., 2005; Novoa-Aponte and Soto Ospina, 2014), which may
mediate Mtb P-type ATPase activation and enhance the metal
toxicity to eliminate Mtb during metal burst in both cell types.
In addition, copper-boosting compounds ATSM and GTSM have
been reported to increase the Copper (Cu) level inMtb instead of
disrupting Cu homeostasis (Speer et al., 2013). Therefore, these
three molecules could be combined as potential multi-molecule
drug for the treatment in both Mφs and DCs during early Mtb
infection.
Furthermore, the results suggest that Rv1098c may help
Rv0667, Rv0762c, and Rv1438 promote host-pathogen
interactions and may help Rv0353 promote the production
of antibodies againstMtb. When mir-636 has been suggested as a
potential drug target to help Mφs increase antibody production
through the activation of Rv0353, Rv1098c plays an important
role in increasing the antibody production in Mφs. Although
Rv1098c has been suggested as a potential drug target to help
both cell types attenuate survival of Mtb, these two drugs that
inhibit mir-636 and Rv1098c, respectively, may produce an
inhibitory action to treat theMtb-infected Mφs.
CONCLUSION
Tuberculosis is a global disease, accounting for almost 2 million
deaths per year. Although, drugs such as isoniazid, rifampin,
and pyrazinamide are used for curing tuberculosis, there is an
urgent need to identify new drugs because of the presence of
drug-resistant strains. Here, for the first time, we used a systems
biology approach, big database mining, and microarray data to
construct GWGEINs in both Mφs and DCs during early Mtb
infection. We identified differences in the defense mechanisms
of the host and pathogen in Mφs and DCs during early Mtb
infection by analyzing HPCNs extracted from GWGEINs via the
PNP method.
Except for the production of cytokines by the host, oxidative
stress is another strategy used to kill pathogens. Oxidative stress
was identified in Mφs and DCs, but it was higher in Mφs.
However, the pathogen can influence the activity of SYK, which
is involved in ROS production through interacting with UBC
in Mφs. Furthermore, ROS is also detrimental to the host since
it could cause DNA damage (Tailleux et al., 2008). Therefore,
Mtb-mediated dysfunction of DNA repair might contribute to
the progression of lung cancer due to long-term accumulation
of mutations in DNA and the interspecies interaction between
Rv1438 and EGFR. In addition, Mtb can also influence the cell
growth mediators RPS10 and PRKAR1A, through interacting
with UBC in Mφs. In contrast, DCs are less susceptible to
Mtb. mir-612 inhibits the expression of PRKAR1A to reduce
cell growth in DCs. DCs collect antigens as well as misfolded
and unfolded proteins to form DALIS, which is then degraded
at the late stage of DC maturation. Antigen peptides are then
loaded ontoMHCmolecules and presented to B cells for antibody
production. The difference in the defense mechanisms between
Mtb-infected Mφs and DCs can be observed in our HPCNs.
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Although, the role of antibody production is unclear as the
control ofMtb requires cellular immunity, especially after antigen
presentation by Mφs, the genes involved in oxidative stress have
been also reported to contribute to the difference in the defense
mechanisms betweenMtb-infected Mφs and DCs (Tailleux et al.,
2008).
Another strategy employed by the host to kill pathogens
is the metal burst in Mtb. Although metals are needed for
survival of the bacteria, the overload of metals becomes toxic.
Mtb evolves adaptive mechanisms to overcome the excess or
absence of Cu in Mtb in order to maintain Cu homeostasis.
Rv0969 acts as an eﬄux pump to transport excess Cu out of
Mtb, and Rv0967 represses the expression of cso in the absence
of Cu. Furthermore, Rv0081 and Rv0324 are metal-dependent
transcriptional factors that participate in the regulation of rv0970.
Although, the function of Rv0970 is still unknown, we predict
that it may play an important role in the metal-dependent
homeostasis pathway. The difference between metal-dependent
homeostasis pathways specific in Mφs and DCs is also shown
in HPCNs in Figure 6B. Although, the function of Rv1675c
is still unknown, we found that it participates in the metal-
dependent homeostasis pathway with higher expression and
more specific interactions in Mφs, indicating its important
defensive role in Mφs. Rv1675c could become a potential drug
target. Another potential drug target is Rv1438, which interacts
with the host proteins EGFR and UBC, and is essential for
the survival of Mtb. The membrane proteins Rv1098c, Rv0967,
Rv0969, Rv0970, Rv0667, Rv1696, and Rv2404c are important for
the survival ofMtb in both cell types and can be easily targeted by
drugs.
We observed that Mφs are more susceptible toMtb than DCs,
and dysfunctions in Mφs such as DNA repair, cell growth and
the constitutive correction of unfolded ormisfolded proteinsmay
easily cause the accumulation of mutations in Mφs. Thus, Mtb-
induced dysfunctions in Mφs suggest that the same dysfunctions
may be present inMtb-infected epithelial cells, and contribute to
the progression of lung cancer.
Finally, we designed a potential multi-molecule drug to deal
with the potential drug targets we proposed. However, because
of the lack of a database that targets Mtb proteins, we explored
several studies to deal with the essential protein Rv1438, the
metal-dependent protein Rv0969, and the increase in Cu levels
in Mtb, from which the multi-molecule drug was designed
(Figure S5).
In the pathogen gene regulation model, we demonstrate that
host-miRNA can inhibit pathogen-gene interactions. However,
the influence of these pathogen-gene interactions on host-
miRNA is still possible although it has not been yet been
elucidated. Therefore, as novel cross-talk mechanisms between
the host and pathogen are identified in the future, the models
used in this study can be improved.
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